We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · February 10, 2014

Chemotherapy Benefit Seen in Esophageal Cancer Patients With Poor Initial Response to Trimodal Therapy

American Journal of Clinical Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

American Journal of Clinical Oncology
The Benefit of Chemotherapy in Esophageal Cancer Patients With Residual Disease After Trimodality Therapy
Am. J. Clin. Oncol 2014 Jan 30;[EPub Ahead of Print], GJ Kim, M Koshy, AL Hanlon, MN Horiba, MJ Edelman, WM Burrows, RJ Battafarano, M Suntharalingam

Further Reading